|
Discovery of COVID-19 and VOC 20 2012/01 life cycles and the proposed drugs to treat patients
|
|
| Author:
|
TAMER I.ABDEL-WAHAB, SHERIF I.ABDEL-WAHAB, EMAN I.ABDEL-WAHAB, MANAL M.ADEL
|
| Abstract:
|
The objective of this study was to detect the role of the proposed anti-virus drugs EGYPTONA and EGYPTOVA in controlling the COVID-19 and VOC 20 2012/01 life cycles in human blood. Some derivatives of neuraminic acid that liked to glycoproteins on the surface of RBCs are the common factor for facilitating infection with COVID-19 in all its strains, but the original strain is dependent on the presence of furin protease as a receptor for the virus more than the other receptors. The patient that has flu symptoms should be checked the level of iron in his blood, such as “serum ferritin” and “serum transferrin to choose the proposed anti-virus drug EGYPTONA or EGYPTOVA. When the level of iron in the blood is higher than the normal level in patients with COVID-19, the proposed anti-virus drug EGYPTONA would be treating most of the disease symptoms. Likewise, the proposed anti-virus drug EGYPTOVA would be suitable in presence of normal iron levels or anemia to treat patients with VOC 20 2012/01.
|
| Keyword:
|
COVID-19 life cycle, VOC 20 2012/01 life cycle, Clinical Reasoning, EGYPTONA drug, EGYPTOVA drug.
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2021.13.02.053
|
| Download:
|
Request For Article
|
|
|